rxstat › Drug prices › Fondaparinux

Fondaparinux (Arixtra) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Fondaparinux 2.5 mg/0.5ml solution costs about $9.86 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee. The brand (Arixtra) lists at $13.46.

Fondaparinux has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABMBONNSNL
2.5 mg/0.5ml Solution$9.86/unitbrand $13.46$9.86/unit$11.19/unitbrand $13.46–$24.40/unitbrand $29.35
7.5 mg/0.6ml Solution$17.50/unitbrand $23.89$18.14/unit$18.14/unit–$19.77/unitbrand $26.04
Plan coverageCoveredPrice listCoveredNot coveredPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay. In Ontario, the plan pays only up to the lowest interchangeable price ($11.19 per unit for 2.5 mg/0.5ml).

Listed products by province

Alberta: 4 products
  • Fondaparinux Sodium Injection 2.5 mg/0.5ml Solution · DRL
    DIN 02406853 · $9.86/unit · Covered
  • Arixtra 2.5 mg/0.5ml Solution · APC
    DIN 02245531 · $13.46/unit · Covered
  • Fondaparinux Sodium Injection 7.5 mg/0.6ml Solution · DRL
    DIN 02406896 · $17.50/unit · Covered
  • Arixtra 7.5 mg/0.6ml Solution · APC
    DIN 02258056 · $23.89/unit · Covered
Manitoba: 4 products
  • Fondaparinux Sodium Injection 2.5 mg/0.5ml Solution · DRL
    DIN 02406853 · $9.86/unit · Price list
  • Arixtra 2.5 mg/0.5ml Solution · ASH
    DIN 02245531 · $10.35/unit · Price list
  • Fondaparinux Sodium Injection 7.5 mg/0.6ml Solution · DRL
    DIN 02406896 · $18.14/unit · Price list
  • Arixtra 7.5 mg/0.6ml Solution · ASH
    DIN 02258056 · $18.36/unit · Price list
Ontario: 4 products
  • Fondaparinux Sodium Injection 2.5 mg/0.5ml Solution · Dr. Reddy's Laboratories Inc.
    DIN 02406853 · $11.19/unit · Covered
  • Arixtra 2.5 mg/0.5ml Solution · Aspen Pharma Trading Limited
    DIN 02245531 · $13.46/unit · Covered
  • Fondaparinux Sodium Injection 7.5 mg/0.6ml Solution · Dr. Reddy's Laboratories Inc.
    DIN 02406896 · $18.14/unit · Covered
  • Arixtra 7.5 mg/0.6ml Solution · Aspen Pharma Trading Limited
    DIN 02258056 · no listed price · Covered
Nova Scotia: 4 products
  • Arixtra 2.5 mg/0.5ml Solution · APN
    DIN 02245531 · no listed price · Not covered
  • Fondaparinux Sodium Injection 2.5 mg/0.5ml Solution · RCH
    DIN 02406853 · no listed price · Not covered
  • Arixtra 7.5 mg/0.6ml Solution · APN
    DIN 02258056 · no listed price · Not covered
  • Fondaparinux Sodium Injection 7.5 mg/0.6ml Solution · RCH
    DIN 02406896 · no listed price · Not covered
Newfoundland and Labrador: 4 products
  • Fondaparinux Sodium Injection 7.5 mg/0.6ml Solution · DRL
    DIN 02406896 · $19.77/unit · Price list
  • Fondaparinux Sodium Injection 2.5 mg/0.5ml Solution · DRL
    DIN 02406853 · $24.40/unit · Price list
  • Arixtra 7.5 mg/0.6ml Solution · ASP
    DIN 02258056 · $26.04/unit · Price list
  • Arixtra 2.5 mg/0.5ml Solution · ASP
    DIN 02245531 · $29.35/unit · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026) · Manitoba Drug Interchangeability Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 5
Reports on file
7

Reports by product

The DIN is printed on your prescription label.

Avoided
ARIXTRA
2.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02245531 · ended Dec 22, 2021 · Delay in shipping of the drug.
Avoided
ARIXTRA
2.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02245531 · ended Dec 22, 2021 · Delay in shipping of the drug.
Resolved
FONDAPARINUX SODIUM INJECTION
2.5MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02406853 · ended Dec 3, 2021 · Delay in shipping of the drug.
Resolved
ARIXTRA
12.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02451700 · ended Jan 2, 2014 · n/a
Resolved
ARIXTRA
12.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02451719 · ended Jan 2, 2014 · n/a
Resolved
ARIXTRA
12.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02258056 · ended Jul 20, 2018 · Delay in shipping of the drug.
Resolved
ARIXTRA
2.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02245531 · ended Jul 13, 2018 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Fondaparinux. Health Canada has 7 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Fondaparinux is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AX).

Recent changes

Common questions

How much does Fondaparinux cost in Canada?

Fondaparinux 2.5 mg/0.5ml solution costs about $9.86 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee. The brand (Arixtra) lists at $13.46.

Is Fondaparinux covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Manitoba: price list; Ontario: covered; Nova Scotia: not covered; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Fondaparinux be back in stock in Canada?

Fondaparinux has no active shortage; supply is normal per Health Canada reports.

Why is Fondaparinux in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antithrombotic agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.